A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma

Sorafenib is currently a targeted agent widely used in the treatment of advanced hepatocellular carcinoma (aHCC). However, to date there is still a lack of a reliable marker capable of predicting sorafenib therapeutic responses. Here, we conducted a genome-wide association study (GWAS) to identify c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chih-Lang, Liang, Kung-Hao, Hu, Ching-Chih, Chien, Cheng-Hung, Chen, Li-Wei, Chien, Rong-Nan, Lin, Yang-Hsiang, Yeh, Chau-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862766/
https://www.ncbi.nlm.nih.gov/pubmed/36675198
http://dx.doi.org/10.3390/ijms24021681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862766/
https://www.ncbi.nlm.nih.gov/pubmed/36675198
http://dx.doi.org/10.3390/ijms24021681

Ejemplares similares